VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
+10.99%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$21.7B
AUM Growth
+$1.52B
(+7.6%)
Cap. Flow
-$332M
Cap. Flow
% of AUM
-1.53%
Top 10 Holdings %
Top 10 Hldgs %
30.74%
Holding
733
New
39
Increased
433
Reduced
235
Closed
15
Top Buys
| 1 |
AUY
Yamana Gold, Inc.
AUY
|
$115M |
| 2 |
PPP
Primero Mining Corp
PPP
|
$89.2M |
| 3 |
CRR
Carbo Ceramics Inc.
CRR
|
$86.7M |
| 4 |
Nabors Industries
NBR
|
$84.8M |
| 5 |
BTU
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
|
$72.6M |
Top Sells
| 1 |
MON
Monsanto Co
MON
|
$89.8M |
| 2 |
Schlumberger
SLB
|
$74.9M |
| 3 |
NOV
NOV
|
$73.8M |
| 4 |
SYT
Syngenta Ag
SYT
|
$70.8M |
| 5 |
POT
Potash Corp Of Saskatchewan
POT
|
$69.9M |
Sector Composition
| 1 | Materials | 45.1% |
| 2 | Energy | 26.67% |
| 3 | Healthcare | 4.74% |
| 4 | Industrials | 3.45% |
| 5 | Consumer Staples | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Texas Instruments
TXN
$170B
| $19.1M | 0.09% |
400,032
+38,879
| +11% | +$1.86M |
|
|
DRC
152
DELISTED
DRESSER-RAND GROUP INC
DRC
| $18.2M | 0.08% |
285,507
-28,633
| -9% | -$1.82M |
|
153
Sanofi
SNY
$111B
| $18.1M | 0.08% |
340,839
+30,248
| +10% | +$1.61M |
|
154
Applied Materials
AMAT
$126B
| $17.8M | 0.08% |
790,825
+27,286
| +4% | +$615K |
|
155
Novo Nordisk
NVO
$249B
| $17.5M | 0.08% |
758,188
+72,620
| +11% | +$1.68M |
|
|
ARMH
156
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $17.2M | 0.08% |
380,129
+43,781
| +13% | +$1.98M |
|
157
BioMarin Pharmaceuticals
BMRN
$10.9B
| $17.1M | 0.08% |
274,716
-73,010
| -21% | -$4.54M |
|
|
BRCM
158
DELISTED
BROADCOM CORP CL-A
BRCM
| $16.8M | 0.08% |
452,587
-34,071
| -7% | -$1.26M |
|
159
VEON
VEON
$4B
| $16.6M | 0.08% |
79,245
+4,588
| +6% | +$964K |
|
160
GSK
GSK
$79.8B
| $16.6M | 0.08% |
248,094
+18,557
| +8% | +$1.24M |
|
161
Eli Lilly
LLY
$666B
| $15.8M | 0.07% |
254,841
+15,019
| +6% | +$934K |
|
162
Analog Devices
ADI
$121B
| $15.8M | 0.07% |
292,762
+4,797
| +2% | +$259K |
|
163
AbbVie
ABBV
$376B
| $15.8M | 0.07% |
279,466
-26,013
| -9% | -$1.47M |
|
164
Telkom Indonesia
TLK
$19.1B
| $15.7M | 0.07% |
755,172
-183,620
| -20% | -$3.82M |
|
|
AGN
165
DELISTED
ALLERGAN INC
AGN
| $15.7M | 0.07% |
92,876
-17,481
| -16% | -$2.96M |
|
166
Bristol-Myers Squibb
BMY
$95B
| $15.7M | 0.07% |
322,731
+65,717
| +26% | +$3.19M |
|
167
AGNC Investment
AGNC
$10.6B
| $15.6M | 0.07% |
666,861
+88,582
| +15% | +$2.07M |
|
168
Abbott
ABT
$231B
| $15.5M | 0.07% |
378,885
+20,906
| +6% | +$855K |
|
169
Paramount Gold Nevada
PZG
$74.3M
| $15.3M | 0.07% |
15,923,890
+1,610,731
| +11% | +$1.55M |
|
170
Teva Pharmaceuticals
TEVA
$21.2B
| $15.3M | 0.07% |
291,563
+3,590
| +1% | +$188K |
|
171
AstraZeneca
AZN
$254B
| $15.2M | 0.07% |
408,392
-17,510
| -4% | -$651K |
|
172
Jacobs Solutions
J
$17.2B
| $14.7M | 0.07% |
334,387
-645,967
| -66% | -$28.5M |
|
|
MDVN
173
DELISTED
MEDIVATION, INC.
MDVN
| $14.7M | 0.07% |
382,316
-61,124
| -14% | -$2.36M |
|
174
Tidewater
TDW
$2.83B
| $14.4M | 0.07% |
7,939
+120
| +2% | +$217K |
|
|
PCYC
175
DELISTED
PHARMACYCLICS INC
PCYC
| $14.4M | 0.07% |
160,267
+6,502
| +4% | +$583K |
|